Observational Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Sep 7, 2022; 28(33): 4861-4874
Published online Sep 7, 2022. doi: 10.3748/wjg.v28.i33.4861
Table 5 Consultations and medications of irritable bowel syndrome patients with abdominal pain alone, abdominal discomfort alone, and abdominal pain & discomfort
VariablePain group (n = 233)Discomfort group (n = 83)Pain & discomfort group (n = 51)P value
In the whole disease course
Consultation times per year14.6 ± 6.75.7 ± 6.24.2 ± 4.10.54
Colonoscopies21.9 ± 1.41.5 ± 0.81.6 ± 0.90.22
In the last year
Consultation times14.0 ± 5.74.5 ± 4.54.9 ± 4.70.54
Medications, intermittent and long-term use, %164 (70.4)56 (67.5)43 (84.3)0.09
Antispasmodics use
Use rate29 (12.4)24 (28.9)12 (23.5)0.0023
Response rate22 (75.9)13 (54.2)10 (83.3)0.12
Overall satisfaction to medical care, %125 (53.7)39 (47.0)21 (41.2)0.21